CannTab

Emblem & Canntab Commence Clinical Testing of 12hr Extended Release Tablets

TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) ("Emblem" or the "Company"), through its wholly-owned subsidiary Emblem Cannabis Corporation, a l...